American Gene Technologies gets FDA approval for clinical trial of HIV program

Rockville-based American Gene Technologies (AGT) received approval from the Food and Drug Administration (FDA) to begin Phase 1, the first human clinical trial for AGT’s lead HIV program. AGT will conduct its Phase 1 study at clinical sites in the Baltimore/Washington area and has named Washington Health Institute, University of Maryland, Institute of Human Virology and Georgetown University as its ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *